RU93004547A - Фармацевтический состав на основе tanacetum partheniom, способ его получения и лекарственное средство на его основе - Google Patents

Фармацевтический состав на основе tanacetum partheniom, способ его получения и лекарственное средство на его основе

Info

Publication number
RU93004547A
RU93004547A RU93004547/14A RU93004547A RU93004547A RU 93004547 A RU93004547 A RU 93004547A RU 93004547/14 A RU93004547/14 A RU 93004547/14A RU 93004547 A RU93004547 A RU 93004547A RU 93004547 A RU93004547 A RU 93004547A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
tanacetum
partheniom
obtaining
basis
Prior art date
Application number
RU93004547/14A
Other languages
English (en)
Other versions
RU2104017C1 (ru
Inventor
Бойшер Норберт
Биллингман Инго
Original Assignee
Шапер унд Броммер ГмбХ унд Ко. КГ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4202657A external-priority patent/DE4202657C2/de
Application filed by Шапер унд Броммер ГмбХ унд Ко. КГ filed Critical Шапер унд Броммер ГмбХ унд Ко. КГ
Publication of RU93004547A publication Critical patent/RU93004547A/ru
Application granted granted Critical
Publication of RU2104017C1 publication Critical patent/RU2104017C1/ru

Links

Claims (1)

  1. Фармацевтический состав, представляющий собой смесь многочисленных ингредиентов, в частности из измельченных растений, например, Tanacetum parthenium, являющийся продуктом тонкого помола и экстрации, обеспечивает повышение выхода и неожиданно высокую стабильность активного вещества, если экстрагирование проводят с помощью газа, предпочтительно CO2, в надкритическом состоянии.
RU93004547A 1992-01-31 1993-01-29 Биоактивный экстракт из tanacetum parthenium и способ его получения RU2104017C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4202657.1 1992-01-31
DE4202657A DE4202657C2 (de) 1992-01-31 1992-01-31 Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel

Publications (2)

Publication Number Publication Date
RU93004547A true RU93004547A (ru) 1995-03-10
RU2104017C1 RU2104017C1 (ru) 1998-02-10

Family

ID=6450610

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93004547A RU2104017C1 (ru) 1992-01-31 1993-01-29 Биоактивный экстракт из tanacetum parthenium и способ его получения

Country Status (19)

Country Link
US (1) US5466451A (ru)
EP (1) EP0553658B2 (ru)
JP (1) JP3611869B2 (ru)
CN (1) CN1074927C (ru)
AT (1) ATE150314T1 (ru)
BR (1) BR9300361A (ru)
CA (1) CA2088289C (ru)
CZ (1) CZ286486B6 (ru)
DE (2) DE4202657C2 (ru)
DK (1) DK0553658T4 (ru)
EG (1) EG20104A (ru)
ES (1) ES2099296T5 (ru)
GR (1) GR3023202T3 (ru)
HU (1) HUT64232A (ru)
MX (1) MX9300265A (ru)
PL (1) PL171097B1 (ru)
RU (1) RU2104017C1 (ru)
SK (1) SK279652B6 (ru)
UA (1) UA26917C2 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695931B1 (fr) * 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
WO1999033463A1 (en) * 1997-12-23 1999-07-08 Moser, René SESQUITERPENE LACTONES SPECIFICALLY INHIBIT ACTIVATION OF NF-λB BY PREVENTING THE DEGRADATION OF IλB-α AND IλB-$g(b)
DE19800330C2 (de) * 1998-01-07 2002-09-26 Delta 9 Pharma Gmbh Pharmazeutisch wirksamer CO¶2¶-Extrakt aus Tanacetum parthenium
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
GB2340120B (en) * 1998-08-01 2003-06-18 Essential Nutrition Ltd Nettle extract containing phytosterols
DE19844836A1 (de) * 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
IT1312342B1 (it) 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
CN1882354B (zh) * 2003-09-12 2012-07-04 捷通国际有限公司 细胞因子调节剂及相关用法
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
DE102004037002B4 (de) * 2004-07-30 2006-06-14 Chemieanlagenbau Chemnitz Gmbh Verfahren zur Herstellung von Dimethylaminoarglabin-Hydrochlorid
US20060222722A1 (en) * 2005-03-30 2006-10-05 Roberts Stephen C Sublingual methods of treatment to alleviate or prevent arthritis
US8409637B2 (en) * 2007-06-21 2013-04-02 Puramed Bioscience Inc. Compositions and methods for treating and preventing migrainous headaches and associated symptoms
CN103524520B (zh) * 2013-09-25 2015-12-09 中国人民解放军第四军医大学 一种从植物原料中提取小白菊内酯的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119454A1 (de) * 1981-05-15 1982-12-09 Haarmann & Reimer Gmbh, 3450 Holzminden Verfahren zur herstellung von konzentrierten extrakten aus frischen pflanzen oder teilen davon, insbesondere frischen kuechenkraeutern
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
GB8428747D0 (en) * 1984-11-14 1984-12-27 Hancock K A Products for treatment of human body
FI73962C (fi) * 1985-03-01 1987-12-10 Yhtyneet Paperitehtaat Oy Foerfarande foer framstaellning av vanillin.
FR2629735B1 (fr) * 1988-04-11 1991-03-22 Agronomique Inst Nat Rech Procede d'extraction au dioxyde de carbone supercritique de composes volatils, et composes obtenus
US4996317A (en) * 1988-08-05 1991-02-26 Kraft General Foods, Inc. Caffeine recovery from supercritical carbon dioxide
US5196575A (en) * 1992-02-19 1993-03-23 Hoechst Celanese Corp. Supercritical separation of isomers of functional organic compounds at moderate conditions

Similar Documents

Publication Publication Date Title
RU93004547A (ru) Фармацевтический состав на основе tanacetum partheniom, способ его получения и лекарственное средство на его основе
CA2088289A1 (en) Pharmaceutically active composition extracted from tanacetum parthenium, process for its extraction, and pharmaceutical composition containing same
US5044091B1 (en) Method of preparing a freeze-dried formulation of a drug
UA26343C2 (uk) Спосіб одержаhhя коhсервоваhого, що містить протеїh людиhи, лікарського засобу для іh'єкційhого або іhфузійhого введеhhя
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
ES2154737T3 (es) Proceso para preparar formas de dosificacion farmaceutica solidas de substancias hidrofobicas.
GB9320668D0 (en) Liposomes containing particulare materials
RU2001101448A (ru) Экстракты из zanthoxylum bungeanum, фармацевтические и косметические составы, содержащие их
GR3018970T3 (en) Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions.
CA2250010A1 (en) Denaturants for sympathomimetic amine salts
DK624287A (da) Komprimeret tablet eller kapsel
EP0009609A3 (en) Adjuvant for promoting absorption of therapeutically active substances through the digestive tract, pharmaceutical composition comprising said adjuvant and process for preparing said pharmaceutical composition; enamine derivatives
AU2923389A (en) A pharmaceutical composition
FR2613223B1 (fr) Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation
GR1002034B (en) Process for the preparation of dry processed particles dry processed particles thus obtained and pharmaceutical compositions containing such particles.
ATE139446T1 (de) Arzneimittel zur behandlung von erregungszuständen und nervendysfunktionen
AU9335798A (en) Method for producing medicinal plant extracts
CA2093914A1 (en) Antineoplastic drug of plant extraction and process for the preparation thereof
NO930271L (no) Antineoplastisk kjemoterapeutika av planteopprinnelse medhoey selektivitet og svaert redusert toksisitet, og fremgangsmaate for fremstilling derav
ATE84219T1 (de) Extrakt arzneimittel.
CA2076527A1 (en) A process for the production of solid forms of active substances and the products obtained in this way
Lavrenova Effect of plant polysaccharides on blood coagulation activity in animals
ZA917700B (en) Peptide and pseudopeptide compounds that are therapeutically active in the blood coagulation cascade,process for the preparation thereof,and pharmaceutical compositions containing them
KR970000237A (ko) 에이즈(aids)의 치료 및 면역기능강화용 조성물